CHAD M ROBINS Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHAD M ROBINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of CHAD M ROBINS for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |